The TTS Starzl Innovation Award is named
after Tom Starzl who was best known for his
contributions to the field of organ
transplantation, and often referred to as the
“father of transplantation”. The award
recognizes individuals who, though advanced
and original work, have contributed
significantly to transplantation, thereby
reflecting the spirit pioneered by Dr. Starzl.
Application Extended Deadline
May 22, 2020
Supported by
Early in his career, Dr. Starzl recognized the
importance of deceased donation. He
pioneered many facets of transplantation,
including immunosuppressive drug
development, organ preservation, tissue
matching, surgical transplant technology, and
developed the team approach to organ
transplantation; thus paving the way for the
success and acceptance of heart, lung,
pancreas, intestinal, liver, and kidney
transplantation. The international impact of
the fruits of seven decades of commitment to
transplantation is shown by estimates of over
600 000 Americans and millions of patients
around the world that have received a
life-saving organ transplantation.
He was also credited as having trained over
1,000 medical and surgical transplant
specialists over his 50 years in clinical
medicine, many of whom have gone on to
successfully develop their own transplant
Eligibility to Award
All full members in good standing will be eligible to be
nominated for this award.
Frequency of Award
The Award will be given at each of the
TTS Biennial congresses.
Selection of the Recipient
The Chair of the Selection Committee will be the then
current TTS President, who will choose a selection
committee of 3 among the Council members.